The U.S.Food and Drug Administration today approved the first generic of Advair Diskus(fluticasone propionate and salmeterol inhalation powder)for the twice-daily treatment of asthma in patients aged four years and ol...The U.S.Food and Drug Administration today approved the first generic of Advair Diskus(fluticasone propionate and salmeterol inhalation powder)for the twice-daily treatment of asthma in patients aged four years and older and maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD).展开更多
文摘The U.S.Food and Drug Administration today approved the first generic of Advair Diskus(fluticasone propionate and salmeterol inhalation powder)for the twice-daily treatment of asthma in patients aged four years and older and maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD).
